Internal Medicine, Endocrinology, Diabetes, & Metabolism · Jersey City, NJ
NPI
1164514063
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
142 Palisade Avenue, Suite 216
Jersey City, NJ, 07306
Phone (201) 714-4668
Groups this clinician bills Medicare through
Medicare paid, 2024
$63K
643 services
Medicare patients, 2024
253
Average age 75
Drug cost, 2024
$1.9M
8,170 prescriptions
Company payments, 2025
$610
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Margaret Ciechanowska was code 99214 (office e&m - established), 509 times for 232 patients. In total Margaret Ciechanowska billed 643 services in 7 codes, and Medicare paid $63K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 509 | 232 | $94.71 | $48K |
| 99215 Office E&M - Established | Office | 53 | 39 | $127.67 | $6,767 |
| 99213 Office E&M - Established | Office | 37 | 24 | $75.19 | $2,782 |
| 99443 Telephone Services | Office | 19 | 12 | $78.02 | $1,482 |
| 99205 Office E&M - New | Office | 14 | 14 | $173.83 | $2,434 |
By year: 2022 $74K for 707 services; 2023 $67K for 647 services; 2024 $63K for 643 services.
Medicare prescription drug claims, 2024
In 2024, the drug Margaret Ciechanowska prescribed most often to Medicare patients was Levothyroxine Sodium, with 689 prescriptions and refills. In total Margaret Ciechanowska wrote 8,170 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 689 | 1,840 | 176 | $6,335 |
| Metformin Hcl Er Metformin Hcl | 483 | 1,391 | 139 | $5,930 |
| Rosuvastatin Calcium Generic | 466 | 1,269 | 148 | $13K |
| Glimepiride Generic | 465 | 1,284 | 128 | $7,623 |
| Metformin Hcl Generic | 438 | 1,191 | 125 | $3,639 |
| Glipizide Er Glipizide | 263 | 758 | 60 | $7,523 |
| Atorvastatin Calcium Generic | 229 | 631 | 75 | $3,236 |
| Farxiga Dapagliflozin Propanediol | 208 | 489 | 56 | $261K |
| Nateglinide Generic | 206 | 564 | 55 | $19K |
| Glipizide Generic | 199 | 547 | 57 | $2,840 |
| Januvia Sitagliptin Phosphate | 178 | 381 | 42 | $202K |
| Ezetimibe Generic | 175 | 474 | 52 | $4,762 |
| Ozempic Semaglutide | 162 | 252 | 33 | $225K |
| Jardiance Empagliflozin | 148 | 323 | 37 | $183K |
| Pioglitazone Hcl Generic | 137 | 411 | 39 | $2,580 |
Brand drugs: 2,217 claims; generic drugs: 5,521 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Margaret Ciechanowska $610 ($610 in general payments such as food, travel and fees) from 11 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $119.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $119 |
| Amneal Pharmaceuticals LLC AMRX | 4 | $70.08 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $65.63 |
| Abbvie Inc. ABBV | 4 | $62.33 |
| Madrigal Pharmaceuticals MDGL | 2 | $58.31 |
| Amgen Inc. AMGN | 3 | $53.67 |
| Novo Nordisk Inc NVO | 3 | $49.71 |
| Corcept Therapeutics CORT | 3 | $49.29 |
| Xeris Pharmaceuticals, Inc. | 3 | $48.65 |
| Insulet Corporation PODD | 1 | $17.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.